PureTech Health Current Valuation vs. Number Of Shares Shorted
| PRTC Stock | USD 22.21 1.18 5.04% |
For PureTech Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of PureTech Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well PureTech Health PLC utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between PureTech Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of PureTech Health PLC over time as well as its relative position and ranking within its peers.
PureTech |
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PureTech Health. If investors know PureTech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PureTech Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of PureTech Health PLC is measured differently than its book value, which is the value of PureTech that is recorded on the company's balance sheet. Investors also form their own opinion of PureTech Health's value that differs from its market value or its book value, called intrinsic value, which is PureTech Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PureTech Health's market value can be influenced by many factors that don't directly affect PureTech Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PureTech Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if PureTech Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PureTech Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
PureTech Health PLC Number Of Shares Shorted vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining PureTech Health's current stock value. Our valuation model uses many indicators to compare PureTech Health value to that of its competitors to determine the firm's financial worth. PureTech Health PLC is rated below average in current valuation category among its peers. It is rated below average in number of shares shorted category among its peers . The ratio of Current Valuation to Number Of Shares Shorted for PureTech Health PLC is about 2,889 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the PureTech Health's earnings, one of the primary drivers of an investment's value.PureTech Current Valuation vs. Competition
PureTech Health PLC is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 3.78 Billion. PureTech Health maintains roughly 28.94 Million in current valuation contributing less than 1% to equities under Health Care industry.
PureTech Number Of Shares Shorted vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
PureTech Health |
| = | 28.94 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
PureTech Health |
| = | 10.02 K |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
PureTech Number Of Shares Shorted Comparison
PureTech Health is currently under evaluation in number of shares shorted category among its peers.
PureTech Health Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in PureTech Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, PureTech Health will eventually generate negative long term returns. The profitability progress is the general direction of PureTech Health's change in net profit over the period of time. It can combine multiple indicators of PureTech Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts. PureTech Health operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people.
PureTech Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on PureTech Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of PureTech Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the PureTech Health's important profitability drivers and their relationship over time.
Use PureTech Health in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if PureTech Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PureTech Health will appreciate offsetting losses from the drop in the long position's value.PureTech Health Pair Trading
PureTech Health PLC Pair Trading Analysis
The ability to find closely correlated positions to PureTech Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace PureTech Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back PureTech Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling PureTech Health PLC to buy it.
The correlation of PureTech Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as PureTech Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if PureTech Health PLC moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for PureTech Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your PureTech Health position
In addition to having PureTech Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Monster Funds Thematic Idea Now
Monster Funds
Solid funds with above average long term performance indicators based on Macroaxis rating system. The Monster Funds theme has 50 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Monster Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Your Equity Center. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
To fully project PureTech Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of PureTech Health PLC at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include PureTech Health's income statement, its balance sheet, and the statement of cash flows.